Literature DB >> 16414355

Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine.

Caroline Duval1, Véronique Touche, Anne Tailleux, Jean-Charles Fruchart, Catherine Fievet, Véronique Clavey, Bart Staels, Sophie Lestavel.   

Abstract

Niemann-Pick C1 like 1 (NPC1L1) is a protein critical for intestinal cholesterol absorption. The nuclear receptors peroxisome proliferator-activated receptor alpha (PPARalpha) and liver X receptors (LXRalpha and LXRbeta) are major regulators of cholesterol homeostasis and their activation results in a reduced absorption of intestinal cholesterol. The goal of this study was to define the role of PPARalpha and LXR nuclear receptors in the regulation of NPC1L1 gene expression. We show that LXR activators down-regulate NPC1L1 mRNA levels in the human enterocyte cell line Caco-2/TC7, whereas PPARalpha ligands have no effect. Furthermore, NPC1L1 mRNA levels are decreased in vivo, in duodenum of mice treated with the LXR agonist T0901317. In conclusion, the present study identifies NPC1L1 as a novel LXR target gene further supporting a crucial role of LXR in intestinal cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414355     DOI: 10.1016/j.bbrc.2005.12.137

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  44 in total

1.  Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.

Authors:  Thomas Pfeifer; Marlene Buchebner; Prakash G Chandak; Jay Patankar; Adelheid Kratzer; Sascha Obrowsky; Gerald N Rechberger; Rajendra S Kadam; Uday B Kompella; Gerhard M Kostner; Dagmar Kratky; Sanja Levak-Frank
Journal:  Curr Pharm Biotechnol       Date:  2011-02-01       Impact factor: 2.837

2.  Regulation of thyroid hormone activation via the liver X-receptor/retinoid X-receptor pathway.

Authors:  Marcelo A Christoffolete; Márton Doleschall; Péter Egri; Zsolt Liposits; Ann Marie Zavacki; Antonio C Bianco; Balázs Gereben
Journal:  J Endocrinol       Date:  2010-02-22       Impact factor: 4.286

3.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

Review 4.  Emerging roles of the intestine in control of cholesterol metabolism.

Authors:  Janine-K Kruit; Albert K Groen; Theo J van Berkel; Folkert Kuipers
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 5.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

6.  Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.

Authors:  François Briand; Morgan Tréguier; Agnès André; Didier Grillot; Marc Issandou; Khadija Ouguerram; Thierry Sulpice
Journal:  J Lipid Res       Date:  2009-10-27       Impact factor: 5.922

Review 7.  Protein mediators of sterol transport across intestinal brush border membrane.

Authors:  J Mark Brown; Liqing Yu
Journal:  Subcell Biochem       Date:  2010

8.  The Drosophila DHR96 nuclear receptor binds cholesterol and regulates cholesterol homeostasis.

Authors:  Michael A Horner; Keith Pardee; Suya Liu; Kirst King-Jones; Gilles Lajoie; Aled Edwards; Henry M Krause; Carl S Thummel
Journal:  Genes Dev       Date:  2009-12-01       Impact factor: 11.361

Review 9.  Liver X receptors in lipid signalling and membrane homeostasis.

Authors:  Bo Wang; Peter Tontonoz
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

10.  Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.

Authors:  Sophie Colin; Olivier Briand; Véronique Touche; Kristiaan Wouters; Morgane Baron; François Pattou; Rémy Hanf; Anne Tailleux; Giulia Chinetti; Bart Staels; Sophie Lestavel
Journal:  Eur Heart J       Date:  2012-07-26       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.